Based on the fact that COX-2 siRNA interference cannot affect the cellular proliferation in OVCAR-3 and HT-29 cancer cell lines, we would like to suggest the restriction of COX-2 siRNA interference for cell lines and xenografts that have a low expression level of EP1-4 receptors. Here, PTGS2 is linked to cancer.